Eloxx Pharmaceuticals, Inc. ELOX

Full chart Compare
Set alert

Price alert · ELOX

All alert types
12.64 USD -0.10 (-0.78%)

Nov 5, 2026, 3:23 PM EST

12.15 Day range 12.66
8.20 52-week range 23.40
YTD
+14.80%
1 year
+14.80%

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 55.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 1
  • 1 month ago 1
  • 2 months ago 1
  • 3 months ago 2

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ELOX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-1.54-1.54 – -1.54-4.80+67.9%00.0%1
Next quarter-1.50-1.50 – -1.50-3.60+58.3%00.0%1
Current year-7.15-7.15 – -7.15-16.65+57.1%00.0%1
Next year-8.93-8.93 – -8.93-7.15-24.9%00.0%1

Upgrades and downgrades

The latest rating changes

ELOX analyst upgrades and downgrades
DateFirmActionFromTo
Jul 11, 2023OppenheimerMaintainedOutperformOutperform
Apr 6, 2023OppenheimerReiterated—Outperform
May 23, 2022Piper SandlerMaintained—Overweight
May 9, 2022HC Wainwright & Co.Maintained—Neutral
Dec 17, 2021OppenheimerInitiated—Outperform
Nov 18, 2021HC Wainwright & Co.Maintained—Neutral
Nov 11, 2021HC Wainwright & Co.Maintained—Neutral
Jun 30, 2021MizuhoInitiated—Buy
May 27, 2021B. Riley SecuritiesInitiated—Buy
Jun 11, 2020CitigroupDowngradeBuyNeutral
May 8, 2020Janney CapitalMaintained—Buy
Mar 6, 2020H.C. WainwrightReiterated—Neutral
Sep 6, 2019Janney CapitalInitiated—Buy
May 15, 2019Canaccord GenuityMaintained—Buy
Dec 24, 2018H.C. WainwrightInitiated—Neutral
Jul 3, 2018CitigroupInitiated—Buy
Jun 29, 2018Canaccord GenuityInitiated—Buy
Jun 26, 2018SunTrust Robinson HumphreyInitiated—Buy
May 1, 2018PiperJaffrayInitiated—Overweight